33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4873)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II AIDS Malignancy Consortium trial of imatinib in AIDS-associated Kaposi's sarcoma (KS)
    Meeting Abstract

    Koon, H. B.; Honda, K.; Lee, J. Y.; Noy, A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • CPX-351 versus cytarabine (CYT) and daunorubicin (DNR) therapy in newly diagnosed AML patients age 60-75: Safety and efficacy in secondary AML (sAML)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Postoperative adjuvant chemotherapy (CTX) use in patients (Pts) with stage II/III rectal cancer treated with neoadjuvant therapy: A National Comprehensive Cancer Network (NCCN) analysis
    Meeting Abstract

    Khrizman, P.; Niland, J. C.; ter Veer, A.; Milne, D.; Dunn, K. B.; Carson, W. E.; Engstrom, P. F.; Shibata, S.; Skibber, J. M.; Weiser, M. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pattern and outcome of disease progression in phase I study of vemurafenib in patients with metastatic melanoma (MM)
    Meeting Abstract

    Kim, K. B.; Flaherty, K. T.; Chapman, P. B.; Sosman, J. A.; Ribas, A.; McArthur, G. A.; Amaravadi, R. K.; Lee, R. J.; Nolop, K. B.; Puzanov, I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Kinahan, K. E.; Sharp, L. K.; Didwania, A.; Seidel, K.; Leisenring, W.; Lacouture, M. E.; Stovall, M.; Robison, L. L.; Krull, K. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): Final results of a University of Chicago Phase II Consortium trial
    Meeting Abstract

    Kindler, H. L.; Campbell, N. P.; Wroblewski, K.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Gandara, D. R.; Antonescu, C.; Stadler, W. M.; Vokes, E. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The biology of early-onset colorectal cancer: An examination of tumor markers, pathology, and survival in a large cohort of patients
    Meeting Abstract

    Khan, S. A.; Morris, M.; Idrees, K.; Gimbel, M.; Rosenberg, S.; Zeng, Z.; Shia, J.; La Quaglia, M. P.; Paty, P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Initial study of bone scan tumor area for early surrogate outcome assessment in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Kim, H. J.; Brown, M. S.; Chu, G. H.; Gjertson, D. W.; Auerbach, M.; Poon, C.; Vidovic, A.; Ramakrishna, B.; Morris, M. J.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Extent of lymphadenectomy in patients with node-positive (FIGO stage IIIC) endometrial carcinoma
    Meeting Abstract

    Khalil, S. S.; Dos Santos, L. A.; Zivanovic, O.; Abu-Rustum, N.; Soslow, R. A.; Alektiar, K. M.; Sabbatini, P.; Makker, V.; Jewell, E. L.; Gardner, G. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save